Calidi Biotherapeutics (CLDI) Q3 2024 Earnings

Aug 13Confirmed
Q2 2024
Q3 2024
-2.75
-2.3
-1.85
-1.4

Details

Expected EPS
-1.45
Actual EPS
-1.4
Surprise EPS
0.05
Surprise Percent
+3.45%

Description

⁨Calidi Biotherapeutics⁩ (⁦CLDI⁩) has reported earnings of ⁦-1.4⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts